BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28614716)

  • 1. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
    Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
    Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
    Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma.
    Hayes MN; McCarthy K; Jin A; Oliveira ML; Iyer S; Garcia SP; Sindiri S; Gryder B; Motala Z; Nielsen GP; Borg JP; van de Rijn M; Malkin D; Khan J; Ignatius MS; Langenau DM
    Cell Stem Cell; 2018 Mar; 22(3):414-427.e6. PubMed ID: 29499154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.
    Vleeshouwer-Neumann T; Phelps M; Bammler TK; MacDonald JW; Jenkins I; Chen EY
    PLoS One; 2015; 10(12):e0144320. PubMed ID: 26636678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma.
    Ignatius MS; Chen E; Elpek NM; Fuller AZ; Tenente IM; Clagg R; Liu S; Blackburn JS; Linardic CM; Rosenberg AE; Nielsen PG; Mempel TR; Langenau DM
    Cancer Cell; 2012 May; 21(5):680-693. PubMed ID: 22624717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma.
    Satheesha S; Manzella G; Bovay A; Casanova EA; Bode PK; Belle R; Feuchtgruber S; Jaaks P; Dogan N; Koscielniak E; Schäfer BW
    Oncogene; 2016 Apr; 35(16):2020-30. PubMed ID: 26189795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
    Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
    Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells.
    Chen SL; Wang SC; Hosking B; Muscat GE
    Mol Endocrinol; 2001 May; 15(5):783-96. PubMed ID: 11328858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
    Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
    Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
    Langenau DM; Keefe MD; Storer NY; Guyon JR; Kutok JL; Le X; Goessling W; Neuberg DS; Kunkel LM; Zon LI
    Genes Dev; 2007 Jun; 21(11):1382-95. PubMed ID: 17510286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
    Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
    J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes.
    Püsküllüoglu M; Lukasiewicz E; Miekus K; Jarocha D; Majka M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):671-7. PubMed ID: 21478114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
    Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
    Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
    Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
    J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma.
    Chen EY; Dobrinski KP; Brown KH; Clagg R; Edelman E; Ignatius MS; Chen JY; Brockmann J; Nielsen GP; Ramaswamy S; Keller C; Lee C; Langenau DM
    PLoS Genet; 2013 Aug; 9(8):e1003727. PubMed ID: 24009521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
    Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SNAI2/CTCF Interaction is Required for
    Sreenivas P; Wang L; Wang M; Challa A; Modi P; Hensch NR; Gryder B; Chou HC; Zhao XR; Sunkel B; Moreno-Campos R; Khan J; Stanton BZ; Ignatius MS
    Mol Cell Biol; 2023; 43(11):547-565. PubMed ID: 37882064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ignatius MS; Hayes MN; Moore FE; Tang Q; Garcia SP; Blackburn PR; Baxi K; Wang L; Jin A; Ramakrishnan A; Reeder S; Chen Y; Nielsen GP; Chen EY; Hasserjian RP; Tirode F; Ekker SC; Langenau DM
    Elife; 2018 Sep; 7():. PubMed ID: 30192230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.